Related Experiment Video
Updated: Jun 25, 2025

10:35
Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
46.4K
Decompression Surgery in Elderly Patients with Hemifacial Spasm Refractory to Botulinum Toxin
Margaret Tugend1, Christina M Ulane2, Kevin Patel2
1Department of Neurological Surgery, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, New York, USA.
Movement Disorders Clinical Practice
|May 23, 2024
Summary
Botulinum toxin is a common treatment for hemifacial spasm in seniors. Surgical decompression remains effective for those unresponsive to injections, with no impact on future success.
Area of Science:
- Neurosurgery
- Neurology
Background:
- Botulinum toxin is an effective hemifacial spasm treatment for elderly patients.
- Some patients experience intolerable side effects or require frequent treatments.
Purpose of the Study:
- To evaluate characteristics and outcomes of elderly patients undergoing facial nerve decompression after botulinum toxin therapy.
- To identify predictors of spasm-freedom post-surgery.
Main Methods:
- Prospective cohort study of 76 elderly patients with hemifacial spasm.
- Logistic regression analyzed predictors: age, sex, side, symptom duration, and prior botulinum toxin treatments.
- Follow-up of at least 2 years.
Main Results:
- 84.2% of patients achieved spasm-freedom at last follow-up (median 44.5 months).
- No significant predictors for long-term spasm-freedom were identified (age, sex, side, symptom duration, prior treatments).
- The most frequent complication was permanent ipsilateral hearing loss (3.9%).
Conclusions:
- Elderly patients can receive botulinum toxin for hemifacial spasm without compromising future surgical decompression outcomes.
- Surgical decompression is an effective therapy for elderly patients with botulinum toxin-refractory hemifacial spasm.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
480
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
480
Skeletal Muscle Relaxants: Adverse Effects
356
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
356
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
674
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
674

